3 of the best ASX 200 shares to buy now with $5,000

Do you have $5,000 ready to invest? Whether you're topping up your portfolio or getting started on your ASX journey, choosing the right shares now could make a meaningful difference over the long term.

In today's uncertain market, quality matters. That means focusing on companies with strong fundamentals, durable earnings, and the ability to grow through cycles.

With that in mind, here are three of the best ASX 200 shares to consider buying right now according to analysts — each offering something a little different, but all built for long-term success. They are as follows:

CSL Ltd (ASX: CSL)

CSL is one of the Australian share market's most iconic companies — and for good reason. This biotech giant develops life-saving therapies across immunology, vaccines, and rare diseases.

The company already has a world class product portfolio, but this doesn't stop it from investing US$1 billion+ into R&D activities each year. This ensures that the company is at the forefront of the industry and has a pipeline of potentially lucrative products to drive its future growth.

Analysts are feeling very positive about the company's outlook and are forecasting double-digit earnings growth in the coming years thanks to the key CSL Behring plasma business.

Bell Potter feels that its shares are cheap based on this growth outlook. As a result, it has put a buy rating and $335.00 price target on its shares.

Pro Medicus Ltd (ASX: PME)

Another ASX 200 share to buy with the $5,000 is Pro Medicus. It is a high-margin, founder-led business that provides advanced imaging software to some of the world's leading hospitals. Its Visage platform helps radiologists analyse medical images faster and more efficiently — a critical need in modern healthcare.

Backed by long-term contracts, Pro Medicus generates strong recurring revenue, incredible operating margins, and returns on capital most companies can only dream of.

And while it trades at a premium, this is arguably justified given its quality and long term growth potential.

Goldman Sachs sees plenty of upside for investors. The broker has put a buy rating and $309.00 price target on its shares.

Woolworths Group Ltd (ASX: WOW)

Finally, Woolworths could be an ASX 200 share to buy according to analysts.

When markets get rocky, Woolworths is the kind of business investors tend to lean on. With a dominant position in Australian supermarkets, a strong loyalty program, and reliable cash flow, it offers defensive stability with modest growth.

While it may not deliver the same excitement as a tech stock, its steady dividends, strong market position and brand loyalty make it a great anchor for any portfolio.

Goldman Sachs is also bullish on this one. It has a buy rating and $36.50 price target on its shares.

The post 3 of the best ASX 200 shares to buy now with $5,000 appeared first on The Motley Fool Australia.

Motley Fool contributor James Mickleboro has positions in CSL and Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Goldman Sachs Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2025